Although direct evidence linking the NRF2-mediated transcriptional activation of ABC transporters to chemoresistance in esophageal cancer (EC) is currently limited, the overexpression of ABC transporters in ESCC, combined with frequent NRF2 pathway alterations, suggests a potential mechanistic link [34]. The gene discussed is ABCG2; the disease is esophageal cancer.